(Q35847164)

10 August 2017

ProBNP-derived peptides in cardiac disease (English)

1 reference

10 August 2017

Goetze JP

1

1 reference

10 August 2017

1 January 2004

1 reference

Scandinavian Journal of Clinical and Laboratory Investigation

10 August 2017

1 reference

10 August 2017

64

1 reference

10 August 2017

5

1 reference

10 August 2017

497-510

1 reference

SPECIFIC GRANULES IN ATRIAL MUSCLE CELLS

10 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

A new natriuretic peptide in porcine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

The role of C-type natriuretic peptide in cardiovascular medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Hypoxia, clonal selection, and the role of HIF-1 in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

21 January 2018

Vasopeptidase inhibition

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Cardiac fibrosis in mice lacking brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

B-type natriuretic peptide in ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510410002913

10.1080/00365510410002913

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15276915